Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Potential predictive factors of osteoporosis in HIV-positive subjects.

Fausto A, Bongiovanni M, Cicconi P, Menicagli L, Ligabò EV, Melzi S, Bini T, Sardanelli F, Cornalba G, Monforte Ad.

Bone. 2006 Jun;38(6):893-7. Epub 2005 Dec 27.

PMID:
16377270
2.

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.

Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

AIDS. 2008 Jan 30;22(3):395-402. doi: 10.1097/QAD.0b013e3282f423dd.

PMID:
18195566
3.

Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.

Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G.

Q J Nucl Med Mol Imaging. 2004 Mar;48(1):39-48.

4.

Predictive factors of vascular intima media thickness in HIV-positive subjects.

Bongiovanni M, Casana M, Cicconi P, Pisacreta M, Codemo R, Pelucchi M, d'Arminio Monforte A, Bini T.

J Antimicrob Chemother. 2008 Jan;61(1):195-9. Epub 2007 Nov 12.

5.

RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men.

Gibellini D, Borderi M, De Crignis E, Cicola R, Vescini F, Caudarella R, Chiodo F, Re MC.

J Med Virol. 2007 Oct;79(10):1446-54.

PMID:
17705184
6.

Osteoporosis and multiple fractures in an antiretroviral-naive, HIV-positive child.

Soler Palacin P, Torrent A, Rossich R, Moraga FA, Yeste D, Carreño JC, Encabo G, Figueras C.

J Pediatr Endocrinol Metab. 2007 Aug;20(8):933-8.

PMID:
17937065
7.
8.

Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.

Hamilton EJ, Rakic V, Davis WA, Chubb SA, Kamber N, Prince RL, Davis TM.

Diabet Med. 2009 Jan;26(1):45-52. doi: 10.1111/j.1464-5491.2008.02608.x.

PMID:
19125760
9.

Evaluation of bone mineral density in Iranian HIV/AIDS patients.

Badie BM, Soori T, Kheirandish P, Izadyar S, SeyedAlinagh S, Foroughi M, Rostamian A, Mohraz M.

Acta Med Iran. 2011;49(7):460-7.

10.

Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.

Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.

Braz J Infect Dis. 2013 Nov-Dec;17(6):707-11. doi: 10.1016/j.bjid.2013.05.009. Epub 2013 Sep 25.

11.

Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART.

Landonio S, Quirino T, Bonfanti P, Gabris A, Boccassini L, Gulisano C, Vulpio L, Ricci E, Carrabba M, Vigevani GM.

Biomed Pharmacother. 2004 Nov;58(9):505-8.

PMID:
15511607
12.

Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.

Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J.

Clin Infect Dis. 2007 Oct 1;45(7):925-32. Epub 2007 Aug 23.

13.

HIV infection--a risk factor for osteoporosis.

Thomas J, Doherty SM.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):281-91. Review.

PMID:
12843738
14.

Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.

Sit D, Kadiroglu AK, Kayabasi H, Atay AE, Yilmaz Z, Yilmaz ME.

Adv Ther. 2007 Sep-Oct;24(5):987-95.

PMID:
18029324
15.

Abnormalities in the bone mineral metabolism in HIV-infected patients.

García Aparicio AM, Muñoz Fernández S, González J, Arribas JR, Peña JM, Vázquez JJ, Martínez ME, Coya J, Martín Mola E.

Clin Rheumatol. 2006 Jul;25(4):537-9. Epub 2005 Oct 6.

PMID:
16208429
16.

Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria.

Kornbluth A, Hayes M, Feldman S, Hunt M, Fried-Boxt E, Lichtiger S, Legnani P, George J, Young J.

Am J Gastroenterol. 2006 Jul;101(7):1546-50.

PMID:
16863559
17.

Bone mineral density in Iranian patients with inflammatory bowel disease.

Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B, Sayyah A, Bashashati M, Jazayeri H, Zand S.

Int J Colorectal Dis. 2006 Dec;21(8):758-66. Epub 2006 Feb 4.

PMID:
16463035
18.

The association of bone mineral density with HIV infection and antiretroviral treatment in women.

Anastos K, Lu D, Shi O, Mulligan K, Tien PC, Freeman R, Cohen MH, Justman J, Hessol NA.

Antivir Ther. 2007;12(7):1049-58.

PMID:
18018763
19.

Identification of the risk factors for osteoporosis among postmenopausal women.

Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, Karacay O, Deveci S.

Maturitas. 2008 Jul-Aug;60(3-4):253-6. doi: 10.1016/j.maturitas.2008.07.011. Epub 2008 Sep 7.

PMID:
18778903
20.

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.

AIDS. 2007 Nov 30;21(18):2473-82.

PMID:
18025884
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk